Présentation de conférence
Ce qui suit est une version texte de la présentation donnée lors de la conférence de travail sur le renforcement de l'évaluation de l'innocuité et de l'efficacité des médicaments déjà sur le marché, tenue les 13, 14 et 15 septembre 2005, à Ottawa en Ontario.
Renforcement de l'évaluation de l'innocuité et de l'efficacité des médicaments en situation réelle
Le texte suivant provient d'un organisme qui n'est pas assujetti à la Loi sur les langues officielles. et il est mis à la disposition du public dans la langue d'origine
Si vous avez besoin d'aide pour accéder aux formats de rechange, tels que PDF, MP3 et fichiers WAV, visitez la section d'aide sur les formats de rechange
(2560K) (2240K)
Organisation de la présentation
![Governance](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_1_e.gif)
![](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_2_e.gif)
![Have a spectrum of complementary data sources](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_3_e.gif)
![To work towards a harmonization of data including a common software infrastructure](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_4_e.gif)
![Local adverse drug reaction reporting structures to building safety](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_5_e.gif)
![To build on existing models for effectiveness and evaluation](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_6_e.gif)
![To integrate drugs more fully into the health system](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_7_e.gif)
![](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_8_e.gif)
![Perspectives on change](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_9_e.gif)
![](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_10_e.gif)
![Perspectives on change](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_11_e.gif)
![Perspectives on change](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_12_e.gif)
![Priority setting](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_13_e.gif)
![Priority setting](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_14_e.gif)
![Priority setting](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_15_e.gif)
![Create Pan](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_16_e.gif)
![Data](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_17_e.gif)
![Data](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_18_e.gif)
![Utilization](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_19_e.gif)
![Perspectives on change](/web/20061211074721im_/http://hc-sc.gc.ca/hcs-sss/images/hpb-dgps/pharma/nps-snpp/securit/sharpe_10_e.gif)
|